Home › Atopic Dermatitis (Eczema) › South Carolina
Atopic Dermatitis (Eczema) clinical trials in South Carolina
8 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in South Carolina.
Cities in South Carolina
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Charleston
RecruitingPhase 3
6 Months – 11 Years · All sexes · Updated Nov 9, 2026 · NCT06311682First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- National Allergy and Asthma Research, LLC, North Charleston
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Tribe Clinical Research, LLC, Greenville
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Nov 5, 2026 · NCT06807281A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07003425This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004, Spartanburg
RecruitingObservational study
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT07290803A Study Evaluating TRIV-573 in Atopic Dermatitis
- Triveni Bio Site #14, Myrtle Beach
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT07782333A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 12, Anderson
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7106, Bluffton
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.